- Home
- FENC vs PFD Comparison
FENC vs PFD Comparison
Compare FENC & PFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- PFD
- Stock Information
- Founded
- FENC 1996
- PFD 1990
- Country
- FENC United States
- PFD United States
- Employees
- FENC N/A
- PFD N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- PFD Investment Managers
- Sector
- FENC Health Care
- PFD Finance
- Exchange
- FENC Nasdaq
- PFD Nasdaq
- Market Cap
- FENC 172.8M
- PFD 148.3M
- IPO Year
- FENC 2001
- PFD N/A
- Fundamental
- Price
- FENC $6.07
- PFD $11.31
- Analyst Decision
- FENC Strong Buy
- PFD
- Analyst Count
- FENC 2
- PFD 0
- Target Price
- FENC $14.00
- PFD N/A
- AVG Volume (30 Days)
- FENC 173.1K
- PFD 33.2K
- Earning Date
- FENC 11-07-2024
- PFD 01-01-0001
- Dividend Yield
- FENC N/A
- PFD 6.30%
- EPS Growth
- FENC N/A
- PFD N/A
- EPS
- FENC N/A
- PFD N/A
- Revenue
- FENC $49,348,000.00
- PFD N/A
- Revenue This Year
- FENC $97.94
- PFD N/A
- Revenue Next Year
- FENC $11.50
- PFD N/A
- P/E Ratio
- FENC N/A
- PFD N/A
- Revenue Growth
- FENC 278.09
- PFD N/A
- 52 Week Low
- FENC $3.96
- PFD $8.53
- 52 Week High
- FENC $11.92
- PFD $11.18
- Technical
- Relative Strength Index (RSI)
- FENC 61.50
- PFD 41.10
- Support Level
- FENC $5.77
- PFD $11.10
- Resistance Level
- FENC $6.35
- PFD $11.80
- Average True Range (ATR)
- FENC 0.39
- PFD 0.17
- MACD
- FENC -0.02
- PFD 0.00
- Stochastic Oscillator
- FENC 51.62
- PFD 16.95
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About PFD Flaherty & Crumrine Preferred and Income Fund Incorporated
Flaherty & Crumrine Prefd Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities, which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.